Home arrow Overweeg je abortus? arrow Bronnen en referenties

Bronnen en referenties

Afdrukken

Referenties en bronnen

  1. F. Gary Cunningham, et al., Williams Obstetrics, McGrawHill:2001.
  2. Michigan Department of Community Health, Informed Consent for Abortion, 2001.
  3. Andrzej Zachwieja, The Development of the Preborn Child, (photos)
  4. American College of Obstetricians & Gynecologists Practice Bulletin, number 67, October 2005.
  5. Warren Hern, Abortion Practice, Philadelphia: J.B. Lippincott Company, 1990.
  6. J. Brind, "Induced Abortion as an Independent Risk Factor for Breast Cancer: A Comprehensive Review and MetaAnalysis," Journal of Epidemiology and Community Health, 50:481496, 1996.
  7. Daling, J. et al, "Risk of Breast Cancer Among Young Women: Relationship to Induced Abortion," Journal of theNational Cancer Institute, Volume 86, #21, 1994.
  8. Garfinkle, B.,et al, "Stress, Depression, and Suicide: A study of Adolescents in Minnesota," Minneapolis: UnivMinnesota Extension Service, 1986.
  9. http://www.guttmacher.org/sections/abortion.php
  10. Gissler, M., et al, Pregnancy associated deaths in Finland 19871994, Acta Obstetricia et Gynecologica Scandinavica 76:651657 (1997).
  11. Gissler, M., et al, Pregnancy associated mortality after birth, spontaneous abortion, or induced abortion in Finland,19872000., American Journal of OB/GYN 190: 422427, 2004.
  12. Reardon, et al., Deaths associated with pregnancy outcome, Southern Med Journal, vol 95(8), Aug 2002.
  13. Speckard, A. & Rue, V. "Post Abortion Syndrome: An Emerging Public Health Concern" Journal of Social Issues 48:3, 95120,1992.
  14. Thorp, J.M., et al, Longterm physical and psychological health consequences of induced abortion: review of theevidence, OB GYN Survey, vol 58(1):6779; 2002.
  15. Induced Abortion; ACOG patient education pamphlet; June 2001.
  16. Howe, et al, Induced abortion and breast cancer; Int J Epidemiol 18:3004; 1989.
  17. Calhoun, B., Induced abortion and risk of later premature births; J of American Physicians and Surgeons; 8(2): 4649; 2003.
  18. Stenchever, et al, Comprehensive Gynecology, 4th Edition, Mosby, Inc. 2001.
  19. Medscape Medical News; FDA Safety Labeling Change: Mifeprex; October 26, 2005. http://www.medscape.com/medscapetoday
  20. Induction of Labor; ACOG Practice Bulletin 10; Clinical management guidelines for OB/GYNs. Nov 99.
  21. Gary, M. and Harrison, D., "Analysis of Severe Adverse Events Related to the Use of Mifepristone as an Abortifacient," The Annals of Pharmacology, vol 40, February 2006.
  22. Rue, V.M., Coleman, P.K., et al; "Induced Abortion and Traumatic Stress: A Preliminary Comparison of American and Russian Women". www.medscimonit.com 2004; 10(10): SR516.
  23. Mifeprex package insert; 2000.
  24. FDA Drug Updates: http://www.fda.gov/cder/drug/infopage/mifepristone/mifepristone_historical.htm
  25. Centers for Disease Control, "Abortion Surveillance U.S., 2003," Morbidity & Mortality Weekly Report, Nov 24, 2006/55/SS11.
  26. TeLinde's Operative Gynecology 8th Edition; Editors J.A. Rock and J.D. Thompson; 1997 LippincottRaven pp 485497.
[ terug ]